Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Lumos Diagnostics Holdings Ltd. ( (AU:LDX) ) has provided an announcement.
Lumos Diagnostics Holdings Ltd has issued 35,341 fully paid ordinary shares following the exercise of 42,000 unquoted options by its employees. This issuance was conducted without disclosure under the Corporations Act, and the company confirms its compliance with relevant statutory provisions, indicating a transparent and regulated approach to its operational activities.
More about Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics specializes in rapid, cost-effective, and comprehensive point-of-care diagnostic test technology, aiding healthcare professionals in accurately diagnosing and managing medical conditions. The company offers customized assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms, focusing on infectious and inflammatory diseases.
Average Trading Volume: 5,211,203
Technical Sentiment Signal: Buy
Current Market Cap: A$133.8M
See more insights into LDX stock on TipRanks’ Stock Analysis page.